Mutations of the retinoblastoma gene, most of which cannot be detected by conventional Southern blotting, are known to cause both the nonhereditary and hereditary forms of retinoblastoma and have been implicated in the development of other cancers. Nonhereditary retinoblastoma is caused by a somatic mutation. Hereditary retinoblastoma is caused by a germ-cell mutation, most often a new one, and thus there is usually no family history of the disease. Unlike patients with the nonhereditary disease, those with the hereditary form are at risk for additional retinoblastomas, and their progeny are at risk for the tumors. We used a sensitive technique of primer-directed enzymatic amplification, followed by DNA sequence analysis, to identify mutations as small as a single nucleotide change in tumors from seven patients with simplex retinoblastoma (with no family history of the disease). In four patients the mutation involved only the tumor cells, and in three it involved normal somatic cells as well as tumor cells but was not found in either parent; thus, these mutations appeared to be new, germ-cell mutations. In addition, we found point mutations in cells from a bladder carcinoma, a small-cell carcinoma of the lung, and another retinoblastoma. We conclude that the technique that we have described can distinguish hereditary from nonhereditary retinoblastoma and that it is useful in risk estimation and genetic counseling.
Source Information
Department of Ophthalmology, Harvard Medical School, Boston, MA.
This article has been cited by other articles:
Gorges, L. L., Lents, N. H., Baldassare, J. J.
(2008). The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F. Am. J. Physiol. Cell Physiol.
295: C1151-C1160
[Abstract][Full Text]
Samowitz, W. S., Slattery, M. L., Sweeney, C., Herrick, J., Wolff, R. K., Albertsen, H.
(2007). APC Mutations and Other Genetic and Epigenetic Changes in Colon Cancer. Mol Cancer Res
5: 165-170
[Abstract][Full Text]
Singh, M., Krajewski, M., Mikolajka, A., Holak, T. A.
(2005). Molecular Determinants for the Complex Formation between the Retinoblastoma Protein and LXCXE Sequences. J. Biol. Chem.
280: 37868-37876
[Abstract][Full Text]
Braggio, E, Bonvicino, C R, Vargas, F R, Ferman, S, Eisenberg, A L A, Seuanez, H N
(2004). Identification of three novel RB1 mutations in Brazilian patients with retinoblastoma by "exon by exon" PCR mediated SSCP analysis. J. Clin. Pathol.
57: 585-590
[Abstract][Full Text]
Paggi, M. G., Giordano, A.
(2001). Who Is the Boss in the Retinoblastoma Family? The Point of View of Rb2/p130, the Little Brother. Cancer Res.
61: 4651-4654
[Abstract][Full Text]
O'Brien, J. M.
(2001). Retinoblastoma: Clinical Presentation and the Role of Neuroimaging. Am. J. Neuroradiol.
22: 427-429
[Full Text]
Sutcliffe, J. E., Brown, T. R. P., Allison, S. J., Scott, P. H., White, R. J.
(2000). Retinoblastoma Protein Disrupts Interactions Required for RNA Polymerase III Transcription. Mol. Cell. Biol.
20: 9192-9202
[Abstract][Full Text]
Claudio, P. P., Howard, C. M., Pacilio, C., Cinti, C., Romano, G., Minimo, C., Maraldi, N. M., Minna, J. D., Gelbert, L., Leoncini, L., Tosi, G. M., Hicheli, P., Caputi, M., Giordano, G. G., Giordano, A.
(2000). Mutations in the Retinoblastoma-related Gene RB2/p130 in Lung Tumors and Suppression of Tumor Growth in Vivo by Retrovirus-mediated Gene Transfer. Cancer Res.
60: 372-382
[Abstract][Full Text]
Cinti, C., Claudio, P. P., Howard, C. M., Neri, L. M., Fu, Y., Leoncini, L., Tosi, G. M., Maraldi, N. M., Giordano, A.
(2000). Genetic Alterations Disrupting the Nuclear Localization of the Retinoblastoma-related Gene RB2/p130 in Human Tumor Cell Lines and Primary Tumors. Cancer Res.
60: 383-389
[Abstract][Full Text]
Hagstrom, S. A., Dryja, T. P.
(1999). Mitotic recombination map of 13cen-13q14 derived from an investigation of loss of heterozygosity in retinoblastomas. Proc. Natl. Acad. Sci. USA
96: 2952-2957
[Abstract][Full Text]
Caulfield, J. L., Wishnok, J. S., Tannenbaum, S. R.
(1998). Nitric Oxide-induced Deamination of Cytosine and Guanine in Deoxynucleosides and Oligonucleotides. J. Biol. Chem.
273: 12689-12695
[Abstract][Full Text]
GOUYER, V., GAZZéRI, S., BOLON, I., DREVET, C., BRAMBILLA, C., BRAMBILLA, E.
(1998). Mechanism of Retinoblastoma Gene Inactivation in the Spectrum of Neuroendocrine Lung Tumors. Am. J. Respir. Cell Mol. Bio.
18: 188-196
[Abstract][Full Text]
Sellers, W. R., Novitch, B. G., Miyake, S., Heith, A., Otterson, G. A., Kaye, F. J., Lassar, A. B., Kaelin, W. G. Jr.
(1998). Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev.
12: 95-106
[Abstract][Full Text]
Lee, N. K., Ye, Y.-W., Chen, J., Li, X., Waber, P. G., Nisen, P. D.
(1993). p53, Retinoblastoma, and Human Papillomavirus in Squamous Cell Carcinoma and Adjacent Normal Mucosa of the Upper Aerodigestive Tract. Arch Otolaryngol Head Neck Surg
119: 1125-1131
[Abstract]
Weinberg, R.
(1991). Tumor suppressor genes. Science
254: 1138-1146
[Abstract]
Wink, D., Kasprzak, K., Maragos, C., Elespuru, R., Misra, M, Dunams, T., Cebula, T., Koch, W., Andrews, A., Allen, J., et, al.
(1991). DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science
254: 1001-1003
[Abstract]
Rustgi, A.K., Dyson, N., Hill, D., Bernards, R.
(1991). The c-myc Oncoprotein Forms a Specific Complex with the Product of the Retinoblastoma Gene. Cold Spring Harb Symp Quant Biol
56: 163-167
[Abstract]
Mittnacht, S., Hinds, P.W., Dowdy, S.F., Weinberg, R.A.
(1991). Modulation of Retinoblastoma Protein Activity during the Cell Cycle. Cold Spring Harb Symp Quant Biol
56: 197-209
[Abstract]
Rideout, W. 3rd, Coetzee, G., Olumi, A., Jones, P.
(1990). 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science
249: 1288-1290
[Abstract]
